Company profile

BeauBrain Healthcare, Inc.

BeauBrain Healthcare, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 13, 2026 and the most recent on May 13, 2026 (Morph). Its most common review panel is Radiology (1 device).

1AI devices

2026First decision

2026Latest decision

1Specialties

Timeline

May 13, 2026 · 510(k) K260032Morph · Radiology · QIH